R Hullmann
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Pharmaceutical studies and practices 2
- Pediatric Urology and Nephrology Studies 1
- Co-authors
- P. Schacht (6 shared papers)G. Arcieri (3 shared papers)B Hampel (1 shared paper)H. Schmidt (1 shared paper)Roger Echols (1 shared paper)Aidan Westwood (1 shared paper)Eric C. Griffith (1 shared paper)Barbara O’Brien (1 shared paper)
- Journals
- Infection (3 papers)The Pediatric Infectious Disease Journal (1 paper)The American Journal of Medicine (1 paper)PubMed (5 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
R Hullmann
9 papers receiving 393 citations
Peers
Comparison fields: 5 of 67
- Pharmacology 238
- Molecular Medicine 73
- Epidemiology 134
- Otorhinolaryngology 15
- Microbiology 22
Countries citing papers authored by R Hullmann
This map shows the geographic impact of R Hullmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Hullmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Hullmann more than expected).
Fields of papers citing papers by R Hullmann
This network shows the impact of papers produced by R Hullmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Hullmann. The network helps show where R Hullmann may publish in the future.
Co-authors
The 13 scholars most cited alongside R Hullmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 137 | |
| 2 | 1991 | 126 | |
| 3 | 1988 | 82 | |
| 4 | 1989 | 75 | |
| 5 | 1988 | 12 | |
| 6 | [Propiramfumarate in a clinical study]. | 1974 | 2 |
| 7 | [Clinical results with azlocillin (author's transl)]. | 1979 | 2 |
| 8 | 1994 | 2 | |
| 9 | [Clinical results with mezlocillin (author's transl)]. | 1979 | 1 |
| 10 | [Blood circulation and ECG under the effect of propiramfumarate. Results of a double blind study]. | 1974 | 1 |
| 11 | [Therapy with an antibiotic combination mezlocillin/oxacillin and clinical experience/First communication: Adults (author's transl)]. | 1979 | 0 |
About R Hullmann
R Hullmann is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Infectious Diseases, Urology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 440 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical studies and practices (2 papers), Antibiotic Use and Resistance (1 paper), Epilepsy research and treatment (1 paper), Metabolism and Genetic Disorders (1 paper), Antifungal resistance and susceptibility (1 paper), Renal Transplantation Outcomes and Treatments (1 paper) and Pediatric Urology and Nephrology Studies (1 paper). The work is most often cited by research in Pharmacology (238 citations), Molecular Medicine (73 citations), Epidemiology (134 citations), Otorhinolaryngology (15 citations) and Microbiology (22 citations). R Hullmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include P. Schacht, G. Arcieri, B Hampel, H. Schmidt, Roger Echols, Aidan Westwood, Eric C. Griffith, Barbara O’Brien, Hendrik Van Poppel and L. Baert. Their work appears in journals such as Infection, The Pediatric Infectious Disease Journal, The American Journal of Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.